Henry Schein Inc $ 69.13 0.69 (1.01%)
HSIC News and Headlines - Henry Schein Inc
Investors may be interested in the following stocks, as they have low price-sales ratios, high profitability and good financial conditions.
Southwest Airlines Co
The first company investors may be interested in is Southwest Airlines Co (LUV), a Dallas, Texas-based passenger airline company serving the U.S. and nearby international markets.
The stock was trading at $34.13 per share at close on July 17 for a price-sales ratio of 0.83, which is less appealing than the industry median of 0.66 but still below 1.
Southwest Airlines Co has a GuruFocus profitability rating of 7 out of 10, driven by a return on
According to the GuruFocus All-In-One Screener, the following health care stocks are popular among guru investors.
Express Scripts Holding Co. (ESRX) is held by 20 gurus. The company, which provides health care management and administration services, has a market cap of $52.06 billion. Its revenue of $101.35 billion has grown 17.70% over a 10-year period.
The stock is trading with a price-earnings ratio of 10.79. As of Tuesday, the share price of $92.33 is 9.24% below its 52-week high and 37.95% above its 52-week low. Over the last 10 years, it has returned a 223% gain.
It’s said that a rising tide lifts all boats, and that axiom might apply to many of the “lesser” companies in the market for animal and pet diagnostic testing. Right now it’s pretty much IDEXX Laboratories Inc. (IDEXX) and everyone else. But some of those trailing the leader might be buoyed by their participation in a market that is forecasted to grow at a compound rate of more than 9% through 2022, reaching more than $3.6 billion, according to leading market intelligence firm Reportbuyer.
One of the reasons is that people are buying more pet health insurance. By 2017, Americans
The guru, who picks stocks based on a company’s potential to increase net income and dividends over time, established a position in Henry Schein Inc. (HSIC) and closed his Amgen Inc. (AMGN) holding.
Carlson invested in 170,000 shares of Henry Schein for an average price of $71.90 per share, allocating 0.46% of the equity portfolio to the position.
The Melville, New York-based distributor of medical, dental and veterinary supplies
U.S. market indexes were in the red Tuesday morning, with investors awaiting inflation data.
Shares of Vipshop Holdings Litd. (VIPS) rose almost 10% on the back of the company posting its financial results for the fourth quarter. The online retail company reported annual net sales growth of 23.3% to $3.70 billion, while its profit advanced to 22 cents per share. Moreover, the results exceeded analysts’ earnings estimates by two cents and revenue expectations by $20 million. In addition, the gross profit increased 17.3% to $805.4 million.
During the quarter, Tencent (HKSE:00700) and JD.com (JD) also invested $863 million in Vipshop,
To achieve long-term capital appreciation, the firm, according to its website, invests in undervalued companies that have good financial strength, a competitive edge and are able to generate free cash flow. The current portfolio of 110 stocks is largely composed of securities in the industrials, consumer cyclical, technology and financial services sectors.
According to its fact sheet, the Olstein All Cap Value Fund outperformed its benchmark, which is the Russell 3000 Value
Shares of Horizon Pharma PLC (HZNP) gained in Monday trading after the company reported financial results for its third quarter. EPS of 26 cents beat analysts' expectations by four cents and revenue of $271.6 million beat estimates by $11.86 million but declined 0.8% year over year.
“Our third-quarter results reflect our dedicated focus on execution, driven by 65 percent year-over-year growth of our diverse portfolio of rare disease medicines,” Chairman, President and CEO Timothy P. Walbert said.Â
Further, the gross profit margin reached 53.8%, down from 59.2% in the prior-year quarter. The non-GAAP gross profit margin was 89.6%, which
According to GuruFocus' list, these stocks have reached their 52-week highs.
Henry Schein reached the 52-week high of $184.17
Henry Schein Inc. (HSIC)Â is engaged in providing health care products and services to office-based dental, animal health and medical practitioners. It also provides its services to government, institutional health care clinics and other alternate care clinics.
Henry Schein distributes health care products in three primary categories – andÂ dental, animal health and medical. The segments represent approximately 50%, 28% and 20% of sales.
Schein also offers office software products, in addition to technical, financial
Shares of Henry Schein, Inc. (NASDAQ:HSIC), a global distributor of dental, medical, and animal health products, declined after reporting an unexpected slowdown in its North American dental and equipment sales. No specific reasons for the slowdown have emerged, and we believe that it is too early to extrapolate a trend. While performance in other divisions was solid, Schein’s earnings guidance was revised downward for the first time in several years. We are monitoring events but remain positive given, in our opinion, the company’s strong management, consistent performance, and large market opportunities.
From Baron Funds' Barron Asset Fund
According to GuruFocus' All-in-One Screener, the following are stocks with market caps above $5 billion that are trading with low price-sales (P/S) ratios.
Delphi Automotive PLC. (DLPH) is trading at about $65, with a P/S ratio of 1.15 and an estimated price-earnings (P/E) multiple of 14.12. The company has a market cap of $17.72 billion and over the last 10 years, the stock has risen by 203%. During the last 52 weeks, the price has been as high as $88.89 and as low as $55.59.
It is engaged in the manufacturing of vehicle components. Its business segments are
Imagine you just had the best week ever.
You got that promotion you’d been hoping for, along with a big raise. Your significant other said “yes” to sex. That worrisome biopsy result came back “benign.”
What are the odds that next week will be better, rather than more typical of your past? Probably pretty slim.
That same principle applies to investing. Periods when everything has been going great for a company, accompanied by superb stock price movement, are usually followed by regressions toward normal.
The financial media love to tout "good news" stories featuring stocks that have already done well.
While ModernGraham supports the bottom-up approach to investing, many investors do utilize the top-down method, whereby an industry is selected before the company itself. With that in mind, here is a look at the best companies of the medical industry, selecting the most promising investment opportunities within that industry and giving a broad look at the industry as a whole.
Out of the more than 500 companies reviewed by ModernGraham, 31 were identified as being closely related to the medical industry. Of those, only three are suitable for the Defensive Investor, 14 are suitable for the Enterprising Investor, and the
AmerisourceBergen Corporation (ABC) is a $22.46 billion market cap company, which is a distributor of pharmaceutical products and related health care services that was formed via the merger of Amerisource Health Corp. and Bergen Brunswig Corp.
The company is one of the top three pharmaceutical distributors, with more than $120 billion in annual revenues. The distribution of pharmaceuticals and related healthcare solutions is extremely competitive, with competitors such as Cardinal Health, Inc. (CAH) and McKesson Corporation (MCK).
AmerisourceBergen is the largest specialty drug distributor in the U.S., with several companies depending on it. The firm operates with lower cost operating
According to GuruFocus list of 52-week highs, Barclays PLC, Ryanair Holdings PLC, Marsh & McLennan Companies Inc, and Henry Schein Inc. have all reached their 52-week highs.
Barclays PLC (BCS) Reached the 52-Week High of $16.79
Barclays PLC was incorporated in England and Wales on July 20, 1896. The company has a market cap of $70.29 billion; its shares were traded at around $16.79 with and P/S ratio of 1.68. The dividend yield of Barclays PLC stocks is 2.39%.
In its first quarter of 2015, Barclays generated net operating income of £5,953m, a decrease of 2% over the
In this article, let's take a look at AmerisourceBergen Corporation (ABC), a $24.87 billion market cap company, which is a distributor of pharmaceutical products and related health care services that was formed via the merger of Amerisource Health Corp. and Bergen Brunswig Corp.
The business of distribution of pharmaceuticals and related health care solutions is very important in the supply chain but also extremely competitive. Competitors include Cardinal Health, Inc. (CAH) and McKesson Corporation (MCK). The company is a key player within the pharmaceutical industry simply because other participants depend on it.
When thinking about
According to GuruFocus list of 52-week highs, Dollar Tree Stores Inc, NetEase Inc, Henry Schein Inc, and Archer-Daniels Midland Co. have all reached their 52-week highs.
Dollar Tree Stores Inc (DLTR) Reached the 52-Week High of $66.39
Dollar Tree Stores, Inc., was incorporated in 1986 in the state of Virginia. Dollar Tree Stores Inc has a market cap of $13.65 billion; its shares were traded at around $66.39 with a P/E ratio of 22.70 and P/S ratio of 1.65. Dollar Tree Stores Inc had an annual average earnings growth of 19.00% over the past 10 years. GuruFocus rated
In this article, let's take a look at AmerisourceBergen Corporation (ABC), a $17.44 billion market cap company, which is a distributor of pharmaceutical products and related health care services that was formed via the merger of Amerisource Health Corp. and Bergen Brunswig Corp.
The business of distribution of pharmaceuticals and related health care solutions is extremely competitive. Competitors include Cardinal Health, Inc. (CAH) and McKesson Corporation (MCK); as well as it competes with regional and local distributors, direct-selling manufacturers, warehousing chain drugstores, specialty distributors, and packaging and health care tech companies. The company plays a critical role within
According to GuruFocus list of 52-week highs, InterContinental Hotels Group PLC, Henry Schein Inc., General Growth Properties Inc. and American Airlines Group Inc. have all reached their 52-week highs.
InterContinental Hotels Group PLC (IHG) Reached the 52-Week High of $39.80
InterContinental Hotels Group PLC, together with its subsidiaries, is engaged in hotels and resorts, with franchising, management, ownership and leasehold interests in over 4,600 establishments, with more than 676,000 guest rooms in 100 countries and territories around the world. Intercontinental Hotels Group Plc has a market cap of $10.31 billion; its shares were traded at around $39.80 with a
|2021-01-22 $ 69.13 (1.01%)|
|2021-01-21 $ 68.44 (-2.48%)|
4 MedTech Underperformers Poised for a Turnaround in 2021 - www.zacks.com
|2021-01-06 $ 69.56 (2.63%)|
Henry Schein (HSIC) Grows Inorganically, Closes JV, Buys Stake - www.zacks.com
|2020-12-15 $ 68.94 (1.28%)|
|2020-12-07 $ 68.73 (0.45%)|
Can Value Investors Henry Schein (HSIC) Stock Right Now? - www.zacks.com
|2020-12-02 $ 66.49 (2.43%)|
|2020-11-11 $ 68.08 (0.12%)|
|2020-11-02 $ 62.22 (-2.14%)|
Henry Schein (HSIC) Q3 Earnings Top Estimates, Margins Dip - www.zacks.com
Henry Schein (HSIC) Tops Q3 Earnings and Revenue Estimates - www.zacks.com
|2020-10-30 $ 63.58 (1.08%)|
Medical Products Earnings Due on Nov 2: STE, HSIC & More - www.zacks.com
Why Henry Schein (HSIC) Might Surprise This Earnings Season - www.zacks.com
|2020-10-29 $ 62.9 (1.48%)|
3 Dental Supplies Stocks Set to Shine on the Industry's Upturn - www.zacks.com
|2020-10-27 $ 65.61 (-1.88%)|
Henry Schein (HSIC) to Report Q3 Earnings: What's in Store? - www.zacks.com
|2020-10-26 $ 66.87 (-1.36%)|
Align (ALGN) Unveils New Product for Better Treatment Option - www.zacks.com
|2020-09-10 $ 63.75 (-1.57%)|
Henry Schein Partners MouthWatch to Grow in Teledentistry - www.zacks.com
|2020-09-08 $ 63.74 (-2.89%)|
Henry Schein (HSIC) Enters Into New Dental Deal With Zyris - www.zacks.com
|2020-09-03 $ 65.98 (-1.36%)|
|2020-08-06 $ 66.98 (-0.22%)|
|2020-08-04 $ 69.13 (-2.5%)|
Henry Schein (HSIC) Q2 Earnings Top Estimates, Margins Dip - www.zacks.com
Henry Schein (HSIC) Reports Break-Even Earnings for Q2 - www.zacks.com
|2020-08-03 $ 70.9 (3.16%)|
Why Earnings Season Could Be Great for Henry Schein (HSIC) - www.zacks.com
|2020-07-28 $ 65.9 (-1.69%)|
Henry Schein (HSIC) to Report Q2 Earnings: What's in Store? - www.zacks.com
|2020-07-24 $ 67.03 (-1.97%)|
|2020-07-13 $ 57.85 (1.21%)|
Henry Schein Banks on Dental Consumable Amid Coronavirus Woes - www.zacks.com
Henry Schein Medical to Expand in Telemedicine With VisualDx - www.zacks.com
|2020-07-02 $ 59.07 (0.36%)|
3 MedTech Stocks to Buy Amid Intensifying Coronavirus Fears - www.zacks.com
|2020-06-22 $ 59.5 (-1.52%)|
Near-Term Outlook Bleak for Medical Dental Supplies Industry - www.zacks.com
|2020-06-19 $ 60.42 (1.77%)|
Henry Schein Dental Software Arm May Rebound Despite Pandemic - www.zacks.com
|2020-06-04 $ 63.28 (0.06%)|
Why Is Henry Schein (HSIC) Up 20% Since Last Earnings Report? - www.zacks.com
|2020-05-26 $ 59.57 (5.04%)|
Henry Schein Sales Drop on Coronavirus Woes, Costs Rise - www.zacks.com
|2020-05-06 $ 53.7 (2.31%)|
|2020-05-05 $ 53.7 (2.31%)|
Henry Schein (HSIC) Q1 Earnings and Revenues Top Estimates - www.zacks.com
|2020-04-28 $ 55.27 (0.75%)|
Henry Schein (HSIC) to Report Q1 Earnings: What's in Store? - www.zacks.com
|2020-04-16 $ 52.58 (0.81%)|
Healthcare ETFs to Gain on Progress in COVID-19 Antibody Tests - www.zacks.com
|2020-04-06 $ 47.14 (1.7%)|
Healthcare Stocks & ETFs to Gain on Coronavirus Test Progress - www.zacks.com
|2020-04-01 $ 48.57 (-3.86%)|
BD Launches New Test to Help Combat the Coronavirus Outbreak - www.zacks.com
|2020-03-31 $ 50.52 (-3.01%)|
Healthcare ETFs Gain on Rising Demand for COVID-19 Tests - www.zacks.com
|2020-03-27 $ 50 (-6.65%)|
Henry Schein (HSIC) Jumps: Stock Rises 7.1% - www.zacks.com
|2020-03-05 $ 59.25 (-3.86%)|
|2020-02-04 $ 69.75 (0.19%)|
|2019-11-08 $ 68.91 (0.25%)|
|2019-03-06 $ 57.7 (-1.99%)|
|2018-12-19 $ 62.03 (-0.77%)|
|2018-10-08 $ 68.18 (-1.66%)|
|2018-08-03 $ 62.89 (1.8%)|
David Carlson Picks Up Henry Schein, Dumps Amgen - GuruFocus.com
|2018-05-04 $ 59.22 (0.7%)|
|2018-05-02 $ 60.04 (-0.37%)|
|2018-04-30 $ 59.58 (-1.03%)|
|2018-04-28 $ 60.2 (0.72%)|
|2018-04-25 $ 58.39 (0.88%)|
|2018-04-21 $ 54.14 (-0.99%)|
|2018-04-12 $ 54.14 (-0.4%)|
|2018-04-11 $ 54.14 (-0.4%)|
|2018-04-10 $ 52.42 (0.13%)|
|2018-04-04 $ 53.71 (2.5%)|
|2018-04-02 $ 51.6 (-2.07%)|
|2018-03-29 $ 51.95 (1.82%)|
|2018-03-27 $ 51.38 (1.48%)|
|2018-03-24 $ 50.63 (-2.03%)|
|2018-03-23 $ 50.63 (-2.03%)|
|2017-06-27 $ 71.68 (-1.13%)|
5 Companies Hit 52-Week Highs - GuruFocus.com
|2016-10-21 $ 59.79 (-0.2%)|
Baron Funds Comments on Henry Schein Inc. - GuruFocus.com
Don't Buy a 'Valuation High' - GuruFocus.com
|2013-02-05 $ 34.41 (0.73%)|
Importance of Leadership in a 5-Star Company - GuruFocus.com
|2011-03-07 $ 26.85 (-1.5%)|
|2011-02-25 $ 27.21 (2.68%)|
|2010-05-14 $ 22.59 (-1.91%)|
|2010-05-12 $ 23.33 (1.39%)|
|2010-03-25 $ 22.66 (-0.92%)|
|2010-03-08 $ 22.19 (-0.45%)|
|2009-05-04 $ 17.9 (9.55%)|
Henry Schein Inc. Reports Operating Results (10-Q) - GuruFocus.com
|2008-12-01 $ 13.05 (-6.79%)|
Taking a Shine to (Henry) Schein, Inc. - GuruFocus.com